KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Return on Invested Capital (2016 - 2025)

Merck (MRK) has disclosed Return on Invested Capital for 17 consecutive years, with 0.15% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Invested Capital rose 6.0% to 0.15% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.15%, a 6.0% increase, with the full-year FY2025 number at 0.16%, up 6.0% from a year prior.
  • Return on Invested Capital was 0.15% for Q4 2025 at Merck, up from 0.12% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.15% in Q4 2025 to a low of 0.33% in Q2 2021.
  • A 5-year average of 0.05% and a median of 0.01% in 2022 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: fell -25bps in 2021, then soared 36bps in 2022.
  • Merck's Return on Invested Capital stood at 0.01% in 2021, then plummeted by -423bps to 0.02% in 2022, then tumbled by -315bps to 0.08% in 2023, then surged by 212bps to 0.08% in 2024, then soared by 72bps to 0.15% in 2025.
  • Per Business Quant, the three most recent readings for MRK's Return on Invested Capital are 0.15% (Q4 2025), 0.12% (Q3 2025), and 0.07% (Q2 2025).